Abstract

Big data analytics (BDA) has been steadily garnering interest among both academicians and users in light of its advantages, drawbacks, and anticipated outcomes. This study aims to investigate the determinants of big data analytics adoption, as also the impact of big data analytics adoption on corporate entrepreneurship. Data on pharmaceutical industry corporations were obtained from 219 responses to a questionnaire. The SPSS 29 and AMOS 29 applications were used to analyze data. The findings show that relative advantages, security concerns, top management support, organizational readiness, competitive pressures, and partner pressures positively influence big data analytics adoption. The results also reveal a positive impact of big data analytics on corporate entrepreneurship. The results of this study can contribute to practitioners becoming competent in diagnosing the important factors that inspire or impede corporations in adopting big data analytics applications. Moreover, this study may offer valuable managerial insights for policymakers to enhance corporate entrepreneurship by efficiently exploiting big data analytics capabilities.